24 results
Thumbnail

D2.289 - Independent Sensitization to Poultry and Fish in a Young Adult

Thumbnail

D2.296 - Heat-Stable Egg Allergens in a Patient With Severe Reactions to Cooked and Raw Hen’s Egg

Thumbnail

D2.298 - Diagnostic performance of skin prick testing with fresh and frozen cow's milk in addition to commercial extract in cow’s milk allergy

Thumbnail

D2.300 - Food allergy and food sensitization in children with Netherton syndrome

Thumbnail

D2.290 - Curcubitaceae allergy, a new enemy identificated in Watermelon

Thumbnail

D2.291 - Trends and Patterns Observed Among Suspected Egg-allergic Children in Hong Kong: A 26-year Retrospective Study

Thumbnail

D2.292 - Effects of Milk Oral Immunotheraphy on Human Basophils in Children with Cow’s Milk Protein Allergy

Thumbnail

D2.293 - Differential Clinical Implications of Peach Allergen Components Pru p 3 and Pru p 7

Thumbnail

D2.294 - Clinical Characteristics of Food-Allergic Children with Peripheral Blood Hypereosinophilia

Thumbnail

D2.297 - Assessing thresholds for undertaking baked milk food challenges

Thumbnail

D2.299 - ARFID: The Hidden Face of Food Allergy?

Thumbnail

D2.301 - High Prevalence of Familial Meat Allergy on the Black Sea Coast: Insights into Alpha-Gal Syndrome

Thumbnail

D3.440 - Long-Term Efficacy and Safety of Donidalorsen for Hereditary Angioedema Among Patients in Europe: A Regional Analysis of the OASISplus Study

Thumbnail

D3.441 - Switching to Donidalorsen for Hereditary Angioedema: 1-Year Results From the Phase 3 OASISplus Study

Thumbnail

D3.444 - Efficacy and Safety of Donidalorsen for Patients With Hereditary Angioedema in Europe Who Switched From Prior Long-Term Prophylaxis: Results From the OASISplus Study

Thumbnail

D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial

Thumbnail

D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial

Thumbnail

D3.438 - Clinical outcomes with navenibart according to baseline attack rate, body mass index, and age: results of the ALPHA-STAR trial

Thumbnail

D3.439 - Donidalorsen For The Treatment Of Hereditary Angioedema: 1-Year Results From The OASISplus Open-Label Extension Cohort

Thumbnail

D3.442 - Patient-Reported Outcomes With Long-Term Donidalorsen Treatment Among Patients In Europe With Hereditary Angioedema: 1-Year Interim Results From The OASISplus Open-Label Extension Cohort